Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pre-fibrotic Myelofibrosis”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Testing effectiveness (Phase 2)Looking for participantsNCT06773195
What this trial is testing

Ruxolitinib in Combination With Ulixertinib in People With Myelofibrosis

Who this might be right for
Myelofibrosis
Memorial Sloan Kettering Cancer Center 37
Large-scale testing (Phase 3)Looking for participantsNCT06468033
What this trial is testing

P1101 in Treating Patients With Early PMF or Overt PMF at Low or Intermediate-1 Risk

Who this might be right for
Primary MyelofibrosisMyeloproliferative Neoplasm
PharmaEssentia 150
Testing effectiveness (Phase 2)Looking for participantsNCT05731245
What this trial is testing

Ropeginterferon Alfa 2b for Early MyelofibrosisDIPSS Low/Intermediate-1 Risk Myelofibrosis

Who this might be right for
Pre-fibrotic Myelofibrosis
National Taiwan University Hospital 50
Testing effectiveness (Phase 2)UnknownNCT04988815
What this trial is testing

Ropeginterferon Alfa 2b for Early Myelofibrosis

Who this might be right for
Primary Myelofibrosis, Prefibrotic StageMyelofibrosis
The University of Hong Kong 50
Not applicableLooking for participantsNCT07362225
What this trial is testing

MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)

Who this might be right for
Polycythemia VeraET (Essential Thrombocythemia)Polycythemia Vera (PV)+52 more
MPN Research Foundation 5,000
Not applicableLooking for participantsNCT07419178
What this trial is testing

A New Diagnostic Algorithm to Non-invasively Track Fibrotic Changes in Myeloproliferative Neoplasms Based on C-C Chemokine Receptor 2 Detection. From Flow Cytometry to the Development of Targeted Positron Emission Tomography Molecular Imaging. Pre-clinical Studies and First In-human Proof of Concept

Who this might be right for
Myelofibrosis (MF)
Azienda Ospedaliero-Universitaria di Parma 265